These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6128867)

  • 61. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 62. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Fagard R; Knockaert D
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure.
    Fitzpatrick D; Ikram H; Nicholls MG; Espiner EA
    Circulation; 1983 Mar; 67(3):613-9. PubMed ID: 6821903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. On the stereospecificity of the beta2-adrenoceptor blocking properties of prenalterol.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1980 Sep; 32(9):659-60. PubMed ID: 6107373
    [No Abstract]   [Full Text] [Related]  

  • 66. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
    Dahlström U; Karlsson E; Wranne B
    Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
    [No Abstract]   [Full Text] [Related]  

  • 67. [Recently registered drugs].
    Harvengt C
    Acta Clin Belg; 1982; 37(5):325-7. PubMed ID: 6130659
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of prenalterol on renal function in normal man.
    Järnberg PO; Westman L
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):603-6. PubMed ID: 6130667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-adrenoceptor blocker intoxication: epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction.
    Kulling P; Eleborg L; Persson H
    Hum Toxicol; 1983 Apr; 2(2):175-81. PubMed ID: 6134663
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prenalterol in the treatment of orthostatic hypotension in Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Knockaert D; Fagard R; Fiocchi R; Amery A; Lijnen P
    Acta Cardiol; 1984; 39(2):147-55. PubMed ID: 6145274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
    Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
    J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE; Bohn I; Hahn B; Kment A; Motz U
    J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol.
    Kenakin TP; Ferris RM
    J Cardiovasc Pharmacol; 1983; 5(1):90-7. PubMed ID: 6186866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
    Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
    Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure.
    Sainsbury EJ; Fitzpatrick D; Ikram H; Nicholls MG; Espiner EA; Ashley JJ
    Eur J Clin Pharmacol; 1985; 28(4):397-403. PubMed ID: 2863151
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction.
    Waagstein F; Hjalmarson AC
    Acta Med Scand Suppl; 1976; 587():193-200. PubMed ID: 1062128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urological aspects of the Shy-Drager syndrome: a urodynamic and telemetric investigation. Incontinence treatment by electrical pacemaker and prenalterol.
    Vereecken RL; Goovaerts J; Knockaert D; Joossens J; Sansen W
    Eur Urol; 1985; 11(1):65-8. PubMed ID: 2859197
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prenalterol as a diagnostic test in patients with pseudoischaemic T waves.
    Capucci A; Pacassoni D; Cavallini C; Magnani B
    Int J Clin Pharmacol Res; 1984; 4(3):185-94. PubMed ID: 6149196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.